Rhythm Pharmaceuticals (RYTM) PT Raised to $57 at Morgan Stanley

March 2, 2021 2:14 AM EST
Get Alerts RYTM Hot Sheet
Price: $21.27 -1.85%

Rating Summary:
    6 Buy, 1 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 17 | Down: 14 | New: 42
Trade Now! 
Join SI Premium – FREE
Morgan Stanley analyst David Lebowitz raised the price target on Rhythm Pharmaceuticals (NASDAQ: RYTM) to $57.00 (from $53.00) while maintaining a Overweight rating.

You May Also Be Interested In

Related Categories

Analyst PT Change